| Place of Origin: | China |
|---|---|
| Brand Name: | Senwayer Brand |
| Certification: | ISO, 9001, USP |
| Model Number: | 51372-29-3 |
| Minimum Order Quantity: | 10grams |
| Price: | Discount is possible if your order is big enough |
| Packaging Details: | 10g, 20g, 50g , 100g, 500g. 1kg, 10kg |
| Delivery Time: | within 2 working days |
| Payment Terms: | T/T in advance, Money Gram, Western Union, Bank Transfer. |
| Supply Ability: | 1000kg/month |
| CAS: | 51372-29-3 | Alias: | Budesonide , Dexbudesonide |
|---|---|---|---|
| Apparence: | Almost White Crystalline Powder | Purity: | 99.5% |
| Stock: | Enough Stock | COA: | Available |
| High Light: | anti inflammatory medications,anti allergy medicine |
||
Medical API Budesonide Dexbudesonide Anti AllergicCAS CAS 51372-29-3 White Powder
Quick detail
Chemical Name:Budesonide
16a(R),17-(Butylidenebis(oxy))-11b,21-dihydroxypregna-1,4-diene-3,20-dione
Cas No.:51372-29-3
Molecular Structure:
Molecular Formula:C25H34O6
Molecular Weight:430.53
Important Specifications
Standard:In-house Standard
Appearance: white or almost white
Assay:≥98%
Packing:15 10kg/Alu foil bag
Budesonide Introduction
Budesonide medication is used to treat certain bowel conditions (such as Crohn's disease,ulcerative colitis). While budesonide does not cure these conditions, it may decrease symptoms such as pain and diarrhea. Budesonide is an anti-inflammatory drug (corticosteroid hormone). It works by decreasing the body's natural defense response (immune response).
How should I take budesonide?
Read the Patient Information Leaflet provided by your pharmacist before you start using budesonide and each time you get a refill. If you have any questions, consult your doctor or pharmacist.
Take this medication by mouth with or without food as directed by your doctor, usually once daily in the morning. Take this medication by mouth with a full glass of water (8 ounces/240 milliliters) unless your doctor directs you otherwise. Swallow this medication whole. Do not crush or chew.
Doing so can release all of the drug at once, increasing the risk of side effects. If you are using the extended-release tablets, do not split the tablets unless they have a score line and your doctor or pharmacist tells you to do so. Swallow the whole or split tablet without crushing or chewing.
The dosage and length of treatment are based on your medical condition, response to treatment, and age.
Budesonide dosing information
| 1. Usual Adult Dose for maintenance treatment of asthma as prophylactic therapy. |
| Initial dose: 360 mcg via oral inhalation twice a day: in some patients an initial dose of 180 mcg twice a day may be adequate Maintenance dose: May increase dose in 1 to 2 weeks if response is not adequate; after asthma stability has been achieved, titrate to the lowest effective dose to reduce the possibility of side effects Maximum dose: 720 mcg twice a day |
| 2. Usual Adult Dose for Crohn's Disease -- Acute: Use: Treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon |
|
Initial dose: 9 mg orally once a day in the morning for up to 8 weeks
-May repeat course for recurring episodes of active disease |
| 3. Use: Treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon |
|
Initial dose: 9 mg orally once a day in the morning for up to 8 weeks
|
| 4. Usual Adult Dose for Crohn's Disease -- Maintenance: |
| Enteric coated capsules: 6 mg orally once a day in the morning for up to 3 months -If symptom control is maintained at 3 months, attempt to taper to complete cessation Use: Maintenance of clinical remission of mild to moderate Crohn's disease involving the ileum and/or the ascending colon for up to 3 months. |
| 5. Usual Adult Dose for Ulcerative Colitis: |
| Extended-release tablets: Initial dose: 9 mg orally once a day in the morning Duration of therapy: Up to 8 weeks |
| 6. Rectal Foam: |
| For Active Mild to Moderate Distal Ulcerative Colitis Extending up to 40 cm from the Anal Verge: 1 metered dose administered rectally twice a day for 2 weeks, then 1 metered dose administered rectally once a day for 4 weeks Use: For the induction of remission in patients with active, mild to moderate ulcerative colitis. |
Interactions
Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist.
Do not start, stop, or change the dosage of any medicines without your doctor's approval.
